Search

Saturday, September 30, 2017

FDA approves Lilly pill for common advanced breast cancer

  1. FDA approves Lilly pill for common advanced breast cancer  Washington Post
  2. FDA approves Verzenio for hormone receptor-positive, HER-2-negative breast cancer  HealioFull coverage

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Headlines